XLO Xilio Therapeutics, Inc.

NASDAQ

$9.04

Xilio Therapeutics, Inc. (XLO) Earnings News

Earnings press releases, previews and reviews for Xilio Therapeutics, Inc. (XLO), newest first.

Wednesday August 12, 2026 7:30 AM ET

Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates

Tuesday May 12, 2026 7:30 AM ET

Xilio Therapeutics Reports First Quarter 2026 Financial Results and Provides Pipeline and Business Updates